FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

34 letters match. Newest first.

  1. NexCell Scientific Inc

    NexCell Scientific markets an unapproved, unlicensed umbilical cord blood cell product with serious manufacturing violations.

    High risk
  2. Blue Horizon International, LLC

    FDA warned Blue Horizon International over unapproved stem cell and exosome biologics marketed for serious diseases without a license.

    High risk
  3. Center For Immunology Science, LLC

    FDA cites Center for Immunology Science for a clinical trial of heat-killed Mycobacterium smegmatis without an Investigational New Drug application.

    High risk
  4. Pamela K. Den Besten, DDS, MS

    FDA warned sponsor-investigator Pamela K. Den Besten for running a pediatric dental gel study without an IND, enrolling 43 subjects.

    High risk
  5. American Behavioral Research Institute, LLC

    FDA warned American Behavioral Research Institute for running a 40-subject Relaxium sleep study without an IND, treating a supplement as a drug.

    High risk
  6. Supreme Rejuvenation, LLC

    FDA warned Supreme Rejuvenation that its exosome products are unapproved new drugs and unlicensed biological products.

    High risk
  7. MG Infusions

    FDA warned MG Infusions it sells unlicensed fecal transplant products online without required approval.

    High risk
  8. Richard W. Foltin, Ph.D.

    FDA warned sponsor Dr. Richard W. Foltin for starting drug trials in people without an IND.

    High risk
  9. Mother Stem Institute, Corp.

    FDA warns Mother Stem Institute over unapproved fat-derived SVF 'stem cell' biologic marketed for serious diseases.

    High risk
  10. Berkeley Biologics, LLC, previously operating as Elutia, Inc. – Orthobiologics Business Unit, formerly Aziyo Biologics, Inc.

    FDA says Berkeley Biologics' viable bone matrix products are unapproved drugs, with donor screening failures tied to tuberculosis infections.

    High risk
  11. Neobiosis, LLC

    FDA warns Neobiosis over unapproved amniotic fluid and umbilical cord products and serious manufacturing quality failures.

    High risk
  12. Akan Biosciences, Inc.

    FDA warned Akan Biosciences over unapproved Ayama injectable and donor-screening failures.

    High risk
  13. Human Microbes

    FDA warned Human Microbes that selling fecal microbiota for transplantation as an unapproved drug and unlicensed biologic lacks required BLA or IND.

    High risk
  14. Kimera Labs, Inc.

    FDA warns Kimera Labs over unapproved exosome and amniotic fluid products and serious sterile manufacturing failures.

    High risk
  15. Abbott Laboratories

    FDA warns Abbott that Similac Probiotic Tri-Blend for preterm infants is an unapproved drug and adulterated supplement.

    High risk
  16. Infinant Health, Inc formerly Evolve Biosystems Inc.

    FDA says Infinant Health's Evivo with MCT Oil probiotic is an unapproved biologic drug and unsafe food additive for preterm infants.

    High risk
  17. Signature Biologics, LLC

    FDA cited Signature Biologics for unapproved, unlicensed Signature Cord and serious sterile manufacturing failures.

    High risk
  18. Stratus Biosystems, LLC dba CellGenuity Regenerative Science

    FDA warns CellGenuity over unapproved amniotic/umbilical products and serious sterility failures.

    High risk
  19. Row1 Inc. dba Regenative Labs

    FDA warned Regenative Labs that its umbilical cord products are unlicensed drugs, made under serious sterility and manufacturing failures.

    High risk
  20. Tyrone L. McCall, M.D./Cornea Associates of Texas

    FDA warns Dallas eye practice Cornea Associates for running a 69-subject drug study without an IND.

    High risk
  21. "David M. Lubeck, M.D./Arbor Centers for EyeCare

    FDA warned Dr. David Lubeck for running a combination-drug study without an IND and enrolling five subjects.

    High risk
  22. Invitrx Therapeutics, Inc.

    Invitrx Therapeutics made unapproved umbilical cord and exosome products and had serious manufacturing deviations.

    High risk
  23. BioLab Sciences, Inc.

    FDA warned BioLab Sciences that its injected amniotic fluid and skin products were unapproved biologics with serious manufacturing violations.

    High risk
  24. Vitti Labs, LLC

    FDA warns Vitti Labs over unapproved umbilical cord and amniotic membrane products and sterile manufacturing failures.

    High risk
  25. Daniel Fred Goodman, M.D./Goodman Eye Center

    FDA warns Dr. Daniel Fred Goodman/Goodman Eye Center over clinical drug study without required FDA application and missing consent/assent.

    High risk
  26. Re-Gen Active Lab, Inc.

    FDA warned Re-Gen Active Lab over unapproved amniotic/umbilical cord injectables and serious sterility failures.

    High risk
  27. CytoDyn, Inc.

    FDA warns CytoDyn over video promoting unapproved leronlimab as safe and effective for COVID-19.

    High risk
  28. Surgenex LLC

    FDA warned Surgenex it sold unapproved umbilical cord and amniotic membrane products for injection without a biologics license and with serious manufacturing problems.

    High risk
  29. Lauren R. Klein, MD, M.S.

    FDA cited Dr. Lauren R. Klein for running two emergency department drug studies without required investigational new drug applications.

    High risk
  30. Jon B. Cole, MD

    FDA warns Dr. Jon B. Cole he ran two pre-hospital drug studies without required INDs, adding risks for pregnant women, children, and intoxicated patients.

    High risk
  31. RAAS Nutritionals, LLC/Rare Antibody Antigen Supply, Inc.

    FDA says RAAS Nutritionals ran human drug studies without required IND applications, despite claiming products were dietary supplements.

    High risk
  32. Kaleido Biosciences, Inc.

    Kaleido Biosciences ran COVID-19 clinical trials of KB109 without required IND, FDA says.

    High risk
  33. Davati Medical Supply LLC

    FDA warned Davati Medical Supply for selling unapproved, unlicensed FLUZALP Quadrivalent influenza vaccine online in the U.S.

    High risk
  34. KDunn and Associates, P.A. dba HealthQuilt

    Houston research sponsor ran a COVID-19 drug study on people without an FDA-approved application or proper consent forms.

    High risk